Asia-Pacific Newborn Screening Market - Industry Trends and Forecast to 2026

Asia-Pacific Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) - Industry Trends and Forecast to 2026

Request-a-sample@

Asia-Pacific market for newborn screening is considered to be one of the most expanding markets in the global healthcare industry. Newborn screening is the testing that diagnoses harmful and fatal disorders in newborns which can adversely affect their long term health. The newborn screening tests can detect around thirty metabolic and genetic diseases and some common are phenylketonuria (PKU), congenital hypothyroidism (CH), galactosemia (GAL), and sickle cell disease. Increased government initiatives to aware people regarding newborn screening are playing a vital role in expansion of newborn screening market. Newborn screening is a mandatory test in over 60 countries including U.S., Australia, and New Zealand. These countries have an Infant Mortality Rate of less than 10 per 1000 births. However, in India, only less than 1.0% of infants are screened and every year over 1.6 million babies are born with birth defects.

Speak-to-analyst@

Segmentation: Asia-Pacific Newborn Screening Market

Asia-Pacific newborn screening market is segmented into five notable segments which are test type, product type, technology, disease type and end user.

• On the basis of test type, the market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test
• On the basis of product type, the market is segmented into instruments, reagents & assay kits
• On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays
• On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others
• On the basis of end user, the market is segmented into pediatric clinics, hospital, clinics

Competitive Analysis: Asia-Pacific Newborn Screening Market

Some of the major players operating in the Asia-Pacific newborn screening market are PerkinElmer Inc., Natus Medical Incorporated, Trivitron Healthcare, Baebies, Inc., Bio-Rad Laboratories, Inc., Danahar, Hill-Rom Services Inc., Intelligent Hearing Systems, Interacoustics A/S, Masimo, Medtronic, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., among others.

Request for Toc@https://www.databridgemarketresearch.com/toc/?dbmr=apac-newborn-screening-market

Global Asia-Pacific Newborn Screening Market Size, Status and Forecast 2018 – 2025

• 1 Market Overview
• 2 Manufacturers Profiles
• 3 Global Asia-Pacific Newborn Screening Sales, Revenue, Market Share and Competition by Manufacturer
• 4 Global Asia-Pacific Newborn Screening Market Analysis by Regions
• 5 North America Global Asia-Pacific Newborn Screening by Countries
• 6 Europe Global Asia-Pacific Newborn Screening by Countries
• 7 Asia-Pacific Global Asia-Pacific Newborn Screening by Countries
• 8 South America Global Asia-Pacific Newborn Screening by Countries
• 9 Middle East and Africa Global Asia-Pacific Newborn Screening by Countries
• 10 Global Asia-Pacific Newborn Screening Market Segment by Type
• 11 Global Asia-Pacific Newborn Screening Market Segment by Application
• 12 Global Asia-Pacific Newborn Screening Market Forecast
• 13 Sales Channel, Distributors, Traders and Dealers
• 14 Research Findings and Conclusion
• 15 Appendixes

Recent Developments

• In May 2019, PerkinElmer Inc, helped parent project Muscular Dystrophy launch a screening program for newborns for muscular dystrophy. It helps the company in increasing market value and market share by creating awareness for newborn screening.
• In February 2018, Vivosonic Inc. received regulatory approval fot Integrity V500 system from the State Food and Drug Administration (SFDA) of the People’s Republic of China in China. This approval expands the Vivosonics’ business in China.
• In February 2018, Vivosonic Inc. received regulatory approval from the ministry of health, labour and welfare to market Integrity V500 system in Japan. This approval expands the business in Japan.

Research Methodology: Asia-Pacific Newborn Screening Market

Primary Respondents: Key Opinion Leaders (KOL’s): Doctors, Nurses, Research Institutes and Medical Professionals. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/apac-newborn-screening-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email:

Global 1,6 hexanediol market is estimated to reach Usd 1525.16 million with a substantial Cagr of 7.5% by the end of 2026. This rise in market value can be attributed due to wide applications of end products, growth in the wind energy sector